COVID-19 Vaccines for the World

10-11 March 2022, The Richard Doll Building, University of Oxford, Oxford, UK

  • Increase font size
  • Default font size
  • Decrease font size


Join the conversation on Twitter – #CVW2022

Progress and Challenges of Developing Vaccines for COVID-19

A novel coronavirus, designated as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan, China and causes the highly infectious disease referred to as COVID-19. COVID-19 has now spread worldwide to become a global pandemic affecting and claiming the lives of millions of people worldwide. COVID-19 is asymptomatic for some individuals and for others it can cause symptoms ranging from flu-like to acute respiratory distress syndrome (ARDS), pneumonia and death. There is now a worldwide effort to develop and distribute effective vaccines against SARS-CoV-2.

CVW 2022 is an important forum to enable vaccine researchers to meet and discuss current developments relating to the existing vaccines and pipeline vaccines and an assessment as to the international vaccination programmes worldwide.

This two day event CVW 2022 is a satellite event to the second international UIV 2022 – UNIVERSAL INFLUENZA VACCINES meeting being held at the University of Oxford, Oxford, UK on 7-9 March 2022.

Further details will be added to these website pages shortly. There will also be instructions for oral/poster abstract submissions to the CVW 2022 meeting.

If you would like to be added to the CVW 2022 emailing list, please contact John Herriot.


CVW 2022 Delegates

Login details will be supplied after you have registered for the event.

CVW 2022 Sponsors

  • DNA Vaccine
  • Vismederi

CVW 2022 Mailing List

E-mail Address
What is 3+2-1?